Skip to main content
. Author manuscript; available in PMC: 2012 Feb 8.
Published in final edited form as: Anticancer Agents Med Chem. 2010 Dec;10(10):722–734. doi: 10.2174/187152010794728657

Table 1.

Tyrosine Kinase Inhibitors [2]

Monoclonal Antibodies Imitinib
Trastuzumab
Cetuximab
Panitumumab
Small Molecule Inhibitors Gefitinib
Erlotinib
Multitargeted Inhibitors Lapatinib
Dasatinib
Sunitinib
Ax+itinib
Vandetanib